Stem Cell Mobilization by Hyperbaric Oxygen
Overview
Physiology
Authors
Affiliations
We hypothesized that exposure to hyperbaric oxygen (HBO(2)) would mobilize stem/progenitor cells from the bone marrow by a nitric oxide (*NO) -dependent mechanism. The population of CD34(+) cells in the peripheral circulation of humans doubled in response to a single exposure to 2.0 atmospheres absolute (ATA) O(2) for 2 h. Over a course of 20 treatments, circulating CD34(+) cells increased eightfold, although the overall circulating white cell count was not significantly increased. The number of colony-forming cells (CFCs) increased from 16 +/- 2 to 26 +/- 3 CFCs/100,000 monocytes plated. Elevations in CFCs were entirely due to the CD34(+) subpopulation, but increased cell growth only occurred in samples obtained immediately posttreatment. A high proportion of progeny cells express receptors for vascular endothelial growth factor-2 and for stromal-derived growth factor. In mice, HBO(2) increased circulating stem cell factor by 50%, increased the number of circulating cells expressing stem cell antigen-1 and CD34 by 3.4-fold, and doubled the number of CFCs. Bone marrow *NO concentration increased by 1,008 +/- 255 nM in association with HBO(2). Stem cell mobilization did not occur in knockout mice lacking genes for endothelial *NO synthase. Moreover, pretreatment of wild-type mice with a *NO synthase inhibitor prevented the HBO(2)-induced elevation in stem cell factor and circulating stem cells. We conclude that HBO(2) mobilizes stem/progenitor cells by stimulating *NO synthesis.
MacLaughlin K, Barton G, MacLaughlin J, Lamers J, Marcou M, OBrien M Front Cell Dev Biol. 2025; 12:1377203.
PMID: 39974348 PMC: 11836035. DOI: 10.3389/fcell.2024.1377203.
Lin L, He M, Zeng Y, Ni X, Guo Y, Xie X Front Oncol. 2025; 15:1410148.
PMID: 39963111 PMC: 11830598. DOI: 10.3389/fonc.2025.1410148.
Emerging Indications for Hyperbaric Oxygen Treatment: Registry Cohort Study.
Tanaka H, Rees J, Zhang Z, Ptak J, Hannigan P, Silverman E Interact J Med Res. 2024; 13:e53821.
PMID: 39078624 PMC: 11372337. DOI: 10.2196/53821.
DellOrso G, Carlucci M, Cesaro S, Olcese E, Balduzzi A, Vendemini F Bone Marrow Transplant. 2024; 59(9):1302-1308.
PMID: 38909124 DOI: 10.1038/s41409-024-02320-4.
Hyperoxia: Effective Mechanism of Hyperbaric Treatment at Mild-Pressure.
Cannellotto M, Yasells Garcia A, Landa M Int J Mol Sci. 2024; 25(2).
PMID: 38255851 PMC: 10815786. DOI: 10.3390/ijms25020777.